The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)

NCT01832558 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

CKD II-III

Interventions

DRUG: Eplerenone
DRUG: Placebo

Sponsor

Medical University of Vienna